ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Arterra Bioscience Spa

Arterra Bioscience Spa (ARBS)

2.06
0.00
(0.00%)
Cerrado 19 Marzo 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
2.06
Postura de Compra
2.02
Postura de Venta
2.08
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
1.78 Rango de 52 semanas 2.40
Capitalización de Mercado [m]
Precio Anterior
2.06
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
7,469
Acciones en circulación
6,658,493
Rendimiento del Dividendo
4.85%
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-
turnover
4.72M
Beneficio neto
1.08M

Acerca de Arterra Bioscience Spa

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
Sede
Naples, Naples, Ita
Fundado
-
Arterra Bioscience Spa is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker ARBS. The last closing price for Arterra Bioscience was 2.06 €. Over the last year, Arterra Bioscience shares have traded in a share price range of 1.78 € to 2.40 €.

Arterra Bioscience currently has 6,658,493 shares in issue. The market capitalisation of Arterra Bioscience is 13.72 € million.

ARBS Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.04-1.904761904762.12.142.06131252.09714286DE
40.041.98019801982.022.141.93103682.04102128DE
120.115.641025641031.952.141.974692.01245902DE
260.041.98019801982.022.141.8594391.96430923DE
520.041.98019801982.022.41.78128932.01225849DE
156-0.04-1.904761904762.12.681.48143282.06607008DE
260-0.005-0.2421307506052.0654.41.48120482.49908313DE

ARBS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Arterra Bioscience?
El precio actual de las acciones de Arterra Bioscience es 2.06 €
¿Cuántas acciones de Arterra Bioscience están en circulación?
Arterra Bioscience tiene 6,658,493 acciones en circulación
¿Cuál es la capitalización de mercado de Arterra Bioscience?
La capitalización de mercado de Arterra Bioscience es EUR 13.72M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Arterra Bioscience?
Arterra Bioscience ha negociado en un rango de 1.78 € a 2.40 € durante el último año
¿Cuál es la moneda de reporte de Arterra Bioscience?
Arterra Bioscience presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Arterra Bioscience?
El último ingresos anual de Arterra Bioscience es EUR 4.72M
¿Cuál es el último beneficio anual de Arterra Bioscience?
El último beneficio anual de Arterra Bioscience es EUR 1.08M
¿Cuál es la dirección registrada de Arterra Bioscience?
La dirección registrada de Arterra Bioscience es VIA BENEDETTO BRIN, 69, NAPLES, NAPLES, 80142
¿Cuál es la dirección del sitio web de Arterra Bioscience?
La dirección del sitio web de Arterra Bioscience es www.arterrabio.it
¿En qué sector industrial opera Arterra Bioscience?
Arterra Bioscience opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
1AAAlcoa Corp
30.885 €
(0.00%)
0
1AAgilent Technologies Inc
117.72 €
(0.00%)
0
19MWMarvell Technology Inc
63.16 €
(0.00%)
0
18TRATraton SE
35.60 €
(0.00%)
0
11COVCovestro AG
58.36 €
(0.00%)
0
1AAAlcoa Corp
30.885 €
(0.00%)
0
1AAgilent Technologies Inc
117.72 €
(0.00%)
0
19MWMarvell Technology Inc
63.16 €
(0.00%)
0
18TRATraton SE
35.60 €
(0.00%)
0
11COVCovestro AG
58.36 €
(0.00%)
0
1AAAlcoa Corp
30.885 €
(0.00%)
0
1AAgilent Technologies Inc
117.72 €
(0.00%)
0
19MWMarvell Technology Inc
63.16 €
(0.00%)
0
18TRATraton SE
35.60 €
(0.00%)
0
11COVCovestro AG
58.36 €
(0.00%)
0
DJPele DJPele 4 minutos hace
Why can't they PR the highlights of the 10-K along with submitting the 10-K? It would be easier for the investment community to digest. Other companies do this all the time.
NWBO
Guzzi62 Guzzi62 5 minutos hace
If they partner now, they can afford to start new trials in several indicators.

They are so many ways they can partner, Alz only, EU 50/50 and any way you can think of.

Further a BP partner will help with applications, advertising in different countries as appropriate.
AVXL
bobroo bobroo 9 minutos hace
I still firmly believe that nobody borrows money to pay about 4X the current share price of a penny stock three years from now.

Now, if what was being bargained for was shares of LQMT AND something else, then I can see where this might actually be a genuine deal. For example, there is
LQMT
allezlOM allezlOM 13 minutos hace
OTCID New rules into effect July 1, $DBMM is already current with that new Rules, but Imagine if on July 1 they start regulating their market and enforcing supply and demand by eliminating the accumulation of OTC derivatives/short (ie Alpine). Imagine if these bad actors tried to cover before all th
DBMM
wagner wagner 15 minutos hace
I guess spac deals are only gamble for the big boys....
USAR has as already told nothing in hands but a great marketing 
NB
$2.00 or no deal $2.00 or no deal 18 minutos hace
***** NEW *****

PURDUE PHARMA L.P. et al v ELITE LABORATORIES INC, et al.

Tuesday, March 18, 2025

https://www.pacermonitor.com/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
allezlOM allezlOM 26 minutos hace
March 18, 2025 FINRA now goes after Alpine Securities for stealing more than $54.5m from investors. / US Supreme Court allows FINRA proceedings against Alpine Securities👍️Collateral effects on $DBMM stock coming...Hi Shorties still here ? 🥳
https://franknez.com/finra-now-goes-
DBMM
$2.00 or no deal $2.00 or no deal 26 minutos hace
Nice try...

https://elitepharma.com/technology-overview/

- "The abuse-deterrent opioid products utilize our patented abuse-deterrent technology that is based on a pharmacological approach."

The Company owns the following patents (as of March 31, 2024):
ELTP
nowwhat2 nowwhat2 27 minutos hace
83,333 OHTL FANS CLONKS and Confirmations

https://investorshub.advfn.com/uimage/uploads/2025/3/19/wbxdlBTC_~_18_CAPT_11pm_83333_wicked_plain.jpg


https://investorshub.advfn.com/uimage/uploads/2025/3/19/rhjcdBTC_~_18_CAPT_11pm_83333_FAN_OHTL_wicked_plain.jpg
BTCUSD
$2.00 or no deal $2.00 or no deal 27 minutos hace
Why haven't you been listening to the recent CC's and reading my posts?

The outstanding share count will be taken care of in the upcoming 1-for-10 reverse stock split.

OMER has 57 million shares outstanding. Elite plus one billion shares outstanding
ELTP
$2.00 or no deal $2.00 or no deal 29 minutos hace
You JUST admitted why Elite's stock is so low.

NO institutional ownership AND many individual investors CAN'T BUY IN.

BUT NO WORRIES, we are uplisting to the Nasdaq VERY SOON via a 1-for-10 reverse split so we can FINALLY realize our TRUE valuation, which is MUCH higher
ELTP
10baggerz 10baggerz 35 minutos hace
the likelihood they are still working in concert as opposed to an appeal process is lower, imho. 45% imho

Are you saying that in your opinion there is a 55% chance that NWBO is NOT working in concert with the MHRA and is now in some form of “an appeal process”?
NWBO
$2.00 or no deal $2.00 or no deal 35 minutos hace
Nice...

Also, 100 PERCENT of this board wants an ALL CASH buyout REGARDLESS of if their shares are in a Roth, Individual account, or a mixture of both.

Thanks.

CASH Buy Out Now, ... ALL of mine is ROTH IRA.....$$$$$$$$$😁
ELTP
$2.00 or no deal $2.00 or no deal 36 minutos hace
Elite ALREADY has opioids on the market.

Learn to keep up.

Good grief...

I think we will move forward with Opioids
ELTP
Seminole Red Seminole Red 36 minutos hace
got it
mwab52 mwab52 39 minutos hace
Wow!!!!!!!!!! Good morning (RNVA-Land & Team)........Go (RNVA & Team)
RNVA
$2.00 or no deal $2.00 or no deal 40 minutos hace
You JUST admitted what Nasrat has been talking about and planning for in all the recent CC's.

And that is we are about to uplist to the Nasdaq to take advantage of the VERY things you mentioned.

Me and Nasrat are BOTH on RECORD stating the 1-for-10 reverse stock split i
ELTP
DruidOracle55 DruidOracle55 42 minutos hace
You must be one of the axxa scammers or delusional "investor". What else-axxa to discover blockchain cure for the cancer via electromagnetic induction?
AXXA
KingSeeker621 KingSeeker621 47 minutos hace
How do you figure it out?

Thanks,
Prapti
https://www.cordlifeindia.com/ website
jeunke22 jeunke22 48 minutos hace
Proto, question from ‘one pumper to another pumper’ , can you repeat the heat issue Ayar MRR ‘s faced and how they were able to solve this issue?
LWLG
ChangnoiPlaza ChangnoiPlaza 49 minutos hace
did I miss the closure of the CH11 case by the FDIC ? Final payment? confused 🤔
COOP
archilles archilles 50 minutos hace
Shortie is desperate bringing old news and BS. What is shortie trying to do?
Auto pen an executive order and
and Fmcc will go to the moon
FMCC
$2.00 or no deal $2.00 or no deal 50 minutos hace
LMAO.

Nasrat doesn't have state capital gains tax.

He planned ahead for the ALL CASH buyout. Did you?

state capital gains
ELTP

Su Consulta Reciente

Delayed Upgrade Clock